Skin regenerative potentials of curcumin

被引:111
作者
Thangapazham, Rajesh L. [1 ]
Sharad, Shashwat [2 ]
Maheshwari, Radha K. [3 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Bethesda, MD 20814 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA
关键词
curcumin; skin regeneration; anticancer; wound healing; chemoprevention; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; HEME OXYGENASE-1; TNF-ALPHA; IN-VITRO; SIGNALING PATHWAYS; FORMULATION DESIGN; DRUG-DELIVERY; EXPRESSION; APOPTOSIS;
D O I
10.1002/biof.1078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Curcumin, an active constituent of the spice turmeric, is well known for its chemopreventive properties and is found to be beneficial in treating various disorders including skin diseases. Curcumin protects skin by quenching free radicals and reducing inflammation through the inhibition of nuclear factor-kappa B. Curcumin also affects other signaling pathways including transforming growth factor- and mitogen-activated protein kinase pathway. Curcumin also modulates the phase II detoxification enzymes which are crucial in detoxification reactions and for protection against oxidative stress. In the present review, the biological mechanisms of the chemopreventive potential of curcumin in various skin diseases like psoriasis, vitiligo, and melanoma is discussed. The application of curcumin in skin regeneration and wound healing is also elucidated. We also explored the recent innovations and advances involved in the development of transdermal delivery systems to enhance the bioavailability of curcumin, particularly in the skin. Recent clinical trials pertaining to the use of curumin in skin diseases establishes its benefits and also the need for additional clinical trials in other diseases are discussed. (c) 2013 BioFactors, 39(1):141149, 2013
引用
收藏
页码:141 / 149
页数:9
相关论文
共 88 条
[1]  
Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161
[2]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[3]   Tetrahydrocurcuminoid Cream Plus Targeted Narrowband UVB Phototherapy for Vitiligo: A Preliminary Randomized Controlled Study [J].
Asawanonda, Pravit ;
Klahan, Siri-On .
PHOTOMEDICINE AND LASER SURGERY, 2010, 28 (05) :679-684
[4]   Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions [J].
Bala, Kiran ;
Tripathy, B. C. ;
Sharma, Deepak .
BIOGERONTOLOGY, 2006, 7 (02) :81-89
[5]   Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment [J].
Basnet, Purusotam ;
Skalko-Basnet, Natasa .
MOLECULES, 2011, 16 (06) :4567-4598
[6]   The Involvement of Smac/DIABLO, p53, NF-kB, and MAPK Pathways in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin [J].
Becatti, Matteo ;
Prignano, Francesca ;
Fiorillo, Claudia ;
Pescitelli, Leonardo ;
Nassi, Paolo ;
Lotti, Torello ;
Taddei, Niccolo .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (09) :1309-1321
[7]   A combination of curcumin and ginger extract improves abrasion wound healing in corticosteroid-impaired hairless rat skin [J].
Bhagavathula, Narasimharao ;
Warner, Roscoe L. ;
DaSilva, Marissa ;
McClintock, Shannon D. ;
Barron, Adam ;
Aslam, Muhammad N. ;
Johnson, Kent J. ;
Varani, James .
WOUND REPAIR AND REGENERATION, 2009, 17 (03) :360-366
[8]  
Cassano N, 2006, INT J IMMUNOPATH PH, V19, P237
[9]   Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy [J].
Chatterjee, Sudipa June ;
Pandey, Siyaram .
CANCER BIOLOGY & THERAPY, 2011, 11 (02) :216-228
[10]   Optimization and Formulation Design of Gels of Diclofenac and Curcumin for Transdermal Drug Delivery by Box-Behnken Statistical Design [J].
Chaudhary, Hema ;
Kohli, Kanchan ;
Amin, Saima ;
Rathee, Permender ;
Kumar, Vikash .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (02) :580-593